» Articles » PMID: 2306556

Bone Disease in Children with Homozygous Beta-thalassemia

Overview
Journal Bone Miner
Date 1990 Jan 1
PMID 2306556
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The histological features of thalassemic bone are imperfectly known, and the roles of bone marrow hyperactivity, iron overload or vitamin D deficiency in the pathogenesis of the disease are not clearly identified. In this study we examined iliac crest biopsies from 17 transfusion-dependent children with homozygous beta-thalassemia and severe radiological skeletal thalassemic changes, including widening of medullary spaces and osteoporosis. Rachitic lesions were not observed. Serum ferritin concentrations were increased in all but one subject. Iron deposits were histochemically detected in bone marrow, at the marrow-bone interface, along cement lines and mineralizing perimeters. Minor changes were present in trabecular bone, and osteomalacia was absent. By contrast, cortical bone exhibited severe changes including fissures and focal mineralization defects. Plasma 25-hydroxyvitamin D (25(OH)D) concentrations measured during the winter (December-May, 6.5 +/- 4.9 ng/ml, mean +/- SD, n = 6) and during the summer (June-November, 13.8 +/- 8.4 ng/ml, n = 9) did not differ from those of age-matched children living in the same country. Seven patients had moderate hypocalcemia but no biological signs suggestive of vitamin D deficiency: all had normal alkaline phosphatase activity, normal or slightly elevated plasma phosphate, only two had low plasma 25(OH)D concentrations and two others supranormal values of plasma immunoreactive parathyroid hormone. These results show that iron overload and vitamin D deficiency do not seem to play an important role in the pathogenesis of thalassemic bone disease, which is characterized by cortical lesions probably related to marrow hyperactivity.

Citing Articles

Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Garcia-Casal M, Pasricha S, Martinez R, Lopez-Perez L, Pena-Rosas J Cochrane Database Syst Rev. 2021; 5:CD011817.

PMID: 34028001 PMC: 8142307. DOI: 10.1002/14651858.CD011817.pub2.


Red Blood Cell Exchange in a Patient With Extramedullary Hematopoiesis and Cor Pulmonale Secondary to Beta Thalassemia.

Kopparthy P, Kelkar A, Aggarwal K, De Filippis S, Fletcher B Cureus. 2021; 13(3):e13638.

PMID: 33824791 PMC: 8011980. DOI: 10.7759/cureus.13638.


Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease.

Patino E, Doty S, Bhatia D, Meza K, Zhu Y, Rivella S Kidney Int. 2020; 98(5):1210-1224.

PMID: 32574618 PMC: 7606334. DOI: 10.1016/j.kint.2020.05.043.


Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China.

Yu U, Chen L, Wang X, Zhang X, Li Y, Wen F BMC Pediatr. 2019; 19(1):375.

PMID: 31646984 PMC: 6813046. DOI: 10.1186/s12887-019-1744-8.


Under-recognized Hypoparathyroidism in Thalassemia.

TangNgam H, Mahachoklertwattana P, Poomthavorn P, Chuansumrit A, Sirachainan N, Chailurkit L J Clin Res Pediatr Endocrinol. 2018; 10(4):324-330.

PMID: 29726397 PMC: 6280323. DOI: 10.4274/jcrpe.0020.